China Diabetes Market Report: 2019-2024

China currently has the highest number of diabetics in the world. The disease has presently reached epidemic proportions in the adult population. Around three decades ago, less than one percent of the Chinese adult population had diabetes. These levels, however, have increased to around 12 percent - making it the diabetes capital of the world.

The rise of diabetes in China can be attributed to a number of factors. Driven by a strong economic growth over the past few decades, the Chinese population has become richer, fatter and less mobile. Apart from urbanisation and sedentary lifestyles, Chinese people are also genetically more vulnerable to diabetes compared to Europeans and many other population groups. Other factors such as poor awareness of health issues, high consumption of white rice, poor healthcare infrastructure, etc. have also driven the prevalence of the disease.

China's diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.

According to the latest report by IMARC Group, titled "China Diabetes Market Report: 2019-2024", the China diabetes market reached a value of US$ 3.37 Billion in 2018, exhibiting a CAGR of 12.48% during 2011-2018. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in China. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Chinese diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the China diabetes market in any form.

What we have achieved in this report:

Comprehensive situation analysis of the Chinese diabetes epidemiology and its dynamics:

Focus of the Analysis:

• Historical, current and future prevalence of diabetes in China
• Historical, current and future prevalence of type-1 and type-2 diabetes in China
• Historical, current and future prevalence of diabetes in the urban and rural regions in China
• Historical, current and future prevalence of diabetes among males and females in China
• Historical, current and future prevalence of diabetes among various age groups in China
• Historical, current and future diagnosis rates for diabetes in China
• Historical, current and future drug treatment rates for diabetes in China

Comprehensive situation analysis of the Chinese Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

• Performance of the Oral Antidiabetics market in China
• Performance of key classes
• Performance of key players
• Market outlook

Comprehensive situation analysis of the Chinese Insulin market and its dynamics:

Focus of the Analysis:

• Performance of the Insulin market in China
• Performance of key classes
• Performance of key players
• Market outlook

Comprehensive situation analysis of the Chinese diabetes diagnostics market and its dynamics:

Focus of the Analysis:

• Performance of the diabetes diagnostics market in China
• Market Segmentation
• Key players
• Market outlook

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
• 2.3.1 Primary Sources
• 2.3.2 Secondary Sources
• 2.4 Market Estimation
• 2.4.1 Bottom-Up Approach
• 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Diabetes Disease Overview

• 5.1 What is Diabetes?
• 5.2 Diabetes Diagnosis and Treatment
• 5.2.1 Diagnosis
• 5.2.2 Treatment
• 5.3 Diabetes Complications

6 China Diabetes Epidemiology

• 6.1 Diabetes Population and Prevalence Rates
• 6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
• 6.3 Population and Prevalence Rates by Region
• 6.4 Population and Prevalence Rates by Gender
• 6.5 Population and Prevalence Rates by Age Group

7 China Diabetes Market

• 7.1 Market Overview
• 7.2 Market Performance
• 7.3 Market Forecast
• 7.4 SWOT Analysis
• 7.4.1 Overview
• 7.4.2 Strengths
• 7.4.3 Weaknesses
• 7.4.4 Opportunities
• 7.4.5 Threats
• 7.5 Value Chain Analysis
• 7.6 Porter's Five Forces Analysis
• 7.6.1 Overview
• 7.6.2 Bargaining Power of Buyers
• 7.6.3 Bargaining Power of Suppliers
• 7.6.4 Degree of Competition
• 7.6.5 Threat of New Entrants
• 7.6.6 Threat of Substitutes
• 7.7 Market Breakup by Segment
• 7.7.1 China Oral Antidiabetics Market
• 7.7.1.1 Historical Market Trends
• 7.7.1.2 Market Breakup by Class
• 7.7.1.3 Market Shares of Key Players
• 7.7.1.4 Market Forecast
• 7.7.2 China Insulin Market
• 7.7.2.1 Historical Market Trends
• 7.7.2.2 Market Breakup by Class
• 7.7.2.3 Market Shares of Key Players
• 7.7.2.4 Market Forecast

8 Competitive Landscape

• 8.1 Competitive Structure
• 8.2 Profiles of Key Players

List of Figures

• Figure 1: The Impact of Diabetes in the Human Body
• Figure 2: Diabetes Complications
• Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2018 & 2024
• Figure 4: Body Mass Index and Relative risk of Type-2 Diabetes
• Figure 5: China: Total Number of Diabetes Patients (in 000), 2011-2018
• Figure 6: China: Total Number of Diabetes Patients Forecast (in 000), 2019-2024
• Figure 7: China (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2011-2018
• Figure 8: China (Type1 & Type2): Total Number of Diabetes Patients Forecast (in 000), 2019-2024
• Figure 9: China (Urban & Rural): Total Number of Diabetes Patients (in 000), 2011-2018
• Figure 10: China (Urban & Rural): Total Number of Diabetes Patients Forecast (in 000), 2019-2024
• Figure 11: China (Male & Female): Total Number of Diabetes Patients (in 000), 2011-2018
• Figure 12: China (Male & Female): Total Number of Diabetes Patients Forecast (in 000), 2019-2024
• Figure 13: China: Total Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79, - in 000), 2011-2018
• Figure 14: China: Total Number of Diabetes Patients Forecast by Age Group (20-39, 40-59, 60-79, - in 000), 2019-2024
• Figure 15: China: Diabetes Drug Industry Overview
• Figure 16: China: Diabetes Drug Market: Sales Value (in Million US$), 2011-2018
• Figure 17: China: Diabetes Drug Market Forecast: Sales Value (in Million US$), 2019-2024
• Figure 18: China: Diabetes Drug Market: SWOT Analysis
• Figure 19: China: Diabetes Drug Market: Value Chain Analysis
• Figure 20: China: Diabetes Drug Market: Porters Five Forces Analysis
• Figure 21: China: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2011-2018
• Figure 22: China: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2019-2024
• Figure 23: China: Oral Antidiabetics Market: Sales Value (in Million US$), 2011-2018
• Figure 24: China: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2011 & 2018
• Figure 25: China: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
• Figure 26: China: Oral Antidiabetics Market Forecast : Sales Value (in Million US$), 2019-2024
• Figure 27: China: Insulin Market: Sales Value (in Million US$), 2011-2018
• Figure 28: China: Breakup of Insulin Market by Class (in %), 2011 & 2018
• Figure 29: China: Insulin Market: Sales Share of Key Players (in %)
• Figure 30: China: Insulin Market Forecast: Sales Value (in Million US$), 2019-2024

List of Tables

• Table 1: Diagnosis of Diabetes
• Table 2: Global: Diabetes Population Breakup by Country (in 000's), 2018 & 2024
• Table 3: China: Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
• Table 4: China (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
• Table 5: China (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
• Table 6: China (Male & Female): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
• Table 7: China: Total Prevalence & Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79 - in 000), 2011, 2018 & 2024
• Table 8: China: Diabetes Drug Market: Competitive Structure